Clinical and virological aspects of HIV2 infection in rhesus monkeys.
To establish an animal model of AIDS, two different "wild" or "adapted" HIV2 Rod and Eho strains were cultivated on monkey cells from different species (baboons, cynomolgus, Rhesus monkeys). Five different available strains were then injected both by intravenous (i.v.) and intracerebral (i.c.) route into ten Rhesus monkeys. Seven animals seroconverted between days 13 and 230. Reverse transcriptase activity in the lymphocyte culture supernatants was detectable in six of the seven animals that seroconverted, and in one animal that remained seronegative. Lymphopenia and a decrease in the CD4+ cell counts were observed in eight animals. One animal, inoculated with HIV2-Rod "wild type," developed a severe cachexia, with dyspnea, and associated neurological symptoms 150 days after inoculation. This animal was sacrificed on day 220. Pathological examination showed typical lesions of actinomycetes infection in the lungs and in the meninges. Another monkey had significant weight loss associated with lymphadenopathies and pancytopenia. These results suggest that in vivo replication of HIV2 in Rhesus monkeys may induce clinical symptoms of immune deficiency. This method is reproducible and may provide a good model for AIDS.
Livartowski
J
J
CRSSA, DPS/SPE, Commissariat à l'Energie Atomique, Fontenay-Aux-Roses, France.
Dormont
D
D
Boussin
F
F
Chamaret
S
S
Guetard
D
D
Vazeux
R
R
Lebon
P
P
Metivier
H
H
Montagnier
L
L
D000818:Animals; D016516:CD4-CD8 Ratio; D004195:Disease Models, Animal; D015483:HIV Antibodies / Q000378:metabolism; D015658:HIV Infections / Q000382:microbiology / Q000503:physiopathology*; D015498:HIV-2 / Q000254:growth & development / Q000472:pathogenicity*; D008253:Macaca mulatta; D014779:Virus Replication
D015483:HIV Antibodies